Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Explore the complexities of scleroderma clinical trials through this comprehensive patient forum session featuring leading experts from the Scleroderma Research Foundation, academic institutions, and pharmaceutical companies. Learn about new and emerging therapies currently available to patients, understand the key design elements and patient benefits of the CONQUEST Clinical Trial, and gain insights into how pharmaceutical companies make investment decisions in drug development. Discover how clinical trial processes work specifically for scleroderma research and what patients need to know when considering participation in studies. The session includes presentations from Gregory Gordon, MD, JD from the Scleroderma Research Foundation, Dr. Dinesh Khanna from the University of Michigan, Dr. Lauren Reinke-Breen from AbbVie, and Dr. Kremena Simitchieva from Boehringer Ingelheim, followed by an interactive panel discussion addressing patient concerns and questions about the clinical trial landscape for scleroderma treatments.
